Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1977 Dec;60(6):1221–1229. doi: 10.1172/JCI108881

Multiple symmetric lipomatosis: a defect in adrenergic-stimulated lipolysis.

G Enzi, E M Inelmen, A Baritussio, P Dorigo, M Prosdocimi, F Mazzoleni
PMCID: PMC372478  PMID: 199616

Abstract

The cellularity of normal and lipomatous adipose tissue and its response to different lipolytic agents have been studied in a group of 10 patients with multiple symmetric lipomatosis (MSL). In MSL patients, fat cells from lipomatous tissue are smaller than normal, uninvolved adipocytes. Fat cells from lipomata show minimal variations in size following conspicuous increase of lipomatous masses. These findings suggest that the growth of lipomata can be attributed to the neoformation of adipocytes rather than to an enlargement in the single fat cells. The incidence of reduced glucose tolerance and of hyperlipoproteinemia is similar in MSL patients and in controls. A significant reduction in plasma free fatty acids was observed in MSL patients after a 24-h fast as well as after noradrenaline infusion. A specific insensitivity of lipomatous tissue to the lipolytic effect of noradrenaline and isoprenaline was observed in vitro, as indicated by glycerol release in the medium, whereas response to theophylline and to dibutyryl cyclic AMP was retained. The lipolytic response to catecholamines was retained. The lipolytic response to catecholamines was normal in the nonlipomatous adipose tissue of MSL patients. In basal conditions ATP concentrations were similar in normal and in lipomatous adipose tissue. However, incubation with noradrenaline induced a significant fall in intracellular ATP levels in normal tissue, whereas no variations were observed in lipomatous tissue. Theophylline, instead, induced a prompt and significant decrease in intracellular ATP levels in lipomatous tissue. These observations indicate that the block in catecholamine-stimulated lipolysis in lipomatous tissue of MSL patients can be localized at a level preceding the formation of cyclic AMP.

Full text

PDF
1221

Images in this article

1222Image
on p.1222

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BJOERNTORP P. THE FATTY ACID RELEASE AND LIPOLYSIS OF HUMAN SUBCUTANEOUS ADIPOSE TISSUE IN VITRO. Metabolism. 1964 Nov;13:1318–1326. doi: 10.1016/0026-0495(64)90151-9. [DOI] [PubMed] [Google Scholar]
  2. Bihler I., Jeanrenaud B. ATP content of isolated fat cells. Effects of insulin, ouabain, and lipolytic agents. Biochim Biophys Acta. 1970 May 5;202(3):496–506. doi: 10.1016/0005-2760(70)90120-7. [DOI] [PubMed] [Google Scholar]
  3. Björntorp P. Lipid mobilization from human subcutaneous adipose tissue in vitro. Acta Med Scand. 1967 Dec;182(6):717–726. doi: 10.1111/j.0954-6820.1967.tb10900.x. [DOI] [PubMed] [Google Scholar]
  4. CHAHROKHI K. [Diffuse symmetrical lipomatosis with cervical predominance]. Rev Laryngol Otol Rhinol (Bord) 1960 Jul-Aug;81:551–578. [PubMed] [Google Scholar]
  5. CLEMENT-COUJARD G., TRUET J. A propos de trois cas de maladie de Launois-Bensaude. Sem Hop. 1953 Feb 6;29(9):409–417. [PubMed] [Google Scholar]
  6. Carlson L. A., Hallberg D., Micheli H. Quantitative studies on the lipolytic response of human subcutaneous and omental adipose tissue to noradrenaline and theophylline. Acta Med Scand. 1969 Jun;185(6):465–469. doi: 10.1111/j.0954-6820.1969.tb07368.x. [DOI] [PubMed] [Google Scholar]
  7. Cole O. R., Hartwell S. W., Jr Symmetric lipomas of the neck. Cleve Clin Q. 1969 Apr;36(2):91–93. doi: 10.3949/ccjm.36.2.91. [DOI] [PubMed] [Google Scholar]
  8. Colomb D., Durand B. Adénolipomatose symétrique de Launois-Bensaude spécialement intense. Bull Soc Fr Dermatol Syphiligr. 1967;74(3):400–401. [PubMed] [Google Scholar]
  9. Colwell J. A., Cruz S. R. Effect of resection of adipose tissue on the diabetes and hyperinsulinism of benign symmetric lipomatosis. Diabetes. 1972 Jan;21(1):13–15. doi: 10.2337/diab.21.1.13. [DOI] [PubMed] [Google Scholar]
  10. Comings D. E., Glenchur H. Benign symmetric lipomatosis. JAMA. 1968 Jan 22;203(4):305–305. [PubMed] [Google Scholar]
  11. DOLE V. P. A relation between non-esterified fatty acids in plasma and the metabolism of glucose. J Clin Invest. 1956 Feb;35(2):150–154. doi: 10.1172/JCI103259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Deparis M., Sarrazin A., Auzépy P., Robineau M., Forti M. F. Cirrhose alcoolique et maladie de Launois-Bensaude. Etude historique, clinique et pathogénique de la lipomatose symétrique diffuse à prédominance cervicale. Rev Int Hepatol. 1968;18(6):799–821. [PubMed] [Google Scholar]
  13. EDWARDS K. D., WHYTE H. M. The simple measurement of obesity. Clin Sci. 1962 Jun;22:347–352. [PubMed] [Google Scholar]
  14. Efendić S. Catecholamines and metabolism of human adipose tissue. 3. Comparison between the regulation of lipolysis in omental and subcutaneous adipose tissue. Acta Med Scand. 1970 Jun;187(6):477–483. [PubMed] [Google Scholar]
  15. FREDRICKSON D. S., LEES R. S. A SYSTEM FOR PHENOTYPING HYPERLIPOPROTEINEMIA. Circulation. 1965 Mar;31:321–327. doi: 10.1161/01.cir.31.3.321. [DOI] [PubMed] [Google Scholar]
  16. Fain J. N. Biochemical aspects of drug and hormone action on adipose tissue. Pharmacol Rev. 1973 Mar;25(1):67–118. [PubMed] [Google Scholar]
  17. Fassina G., Dorigo P., Gaion R. M. Hormone-induced lipolysis and the metabolic pathways providing energy to the cell: a possible role of ATP as a rate-limiting factor. Adv Exp Med Biol. 1975;63:105–122. doi: 10.1007/978-1-4684-3258-9_7. [DOI] [PubMed] [Google Scholar]
  18. Goldrick R. B., McLoughlin G. M. Lipolysis and lipogenesis from glucose in human fat cells of different sizes. Effects of insulin, epinephrine, and theophylline. J Clin Invest. 1970 Jun;49(6):1213–1223. doi: 10.1172/JCI106335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Greene M. L., Glueck C. J., Fujimoto W. Y., Seegmiller J. E. Benign symmetric lipomatosis (Launois-Bensaude adenolipomatosis) with gout and hyperlipoproteinemia. Am J Med. 1970 Feb;48(2):239–246. doi: 10.1016/0002-9343(70)90120-8. [DOI] [PubMed] [Google Scholar]
  20. Grivaux M., Gentilini M., Soulié J., Badoual P. Adénolipomatose symétrique de Launois et Bensaude et troubles du métabolisme lipidique. Sem Hop. 1969 Jun 14;45(28):1958–1966. [PubMed] [Google Scholar]
  21. HALES C. N., RANDLE P. J. Immunoassay of insulin with insulin-antibody precipitate. Biochem J. 1963 Jul;88:137–146. doi: 10.1042/bj0880137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. HUGUENIN A., GOUIRIC R., BROCHIER M. Adénolipomatose symétrique de Launois et Bensaude. Alger Medicale. 1952 Aug-Sep;56(7):375–381. [PubMed] [Google Scholar]
  23. Hamlin H. Subgaleal hematoma caused by hair-pull. JAMA. 1968 Apr 22;204(4):339–339. [PubMed] [Google Scholar]
  24. Heully F., Laurent J., Bigard M. A., Gonand J. P., Gillot J. Anomalies du métabolisme lipidique et glucidique au cours d'une lipomatose de Launois-Bensaude. Presse Med. 1969 Dec 13;77(53):2001–2002. [PubMed] [Google Scholar]
  25. Hirsch J., Batchelor B. Adipose tissue cellularity in human obesity. Clin Endocrinol Metab. 1976 Jul;5(2):299–311. doi: 10.1016/s0300-595x(76)80023-0. [DOI] [PubMed] [Google Scholar]
  26. Hugo N. E., Conway H. Benign symmetric lipomatosis: a case report. Plast Reconstr Surg. 1966 Jan;37(1):69–71. [PubMed] [Google Scholar]
  27. Jeanrenaud B. Adipose tissue dynamics and regulation, revisited. Ergeb Physiol. 1968;60:57–140. doi: 10.1007/BFb0107251. [DOI] [PubMed] [Google Scholar]
  28. KORN E. D. Clearing factor, a heparin-activated lipoprotein lipase. I. Isolation and characterization of the enzyme from normal rat heart. J Biol Chem. 1955 Jul;215(1):1–14. [PubMed] [Google Scholar]
  29. Kodish M. E., Alsever R. N., Block M. B. Benign symmetric lipomatosis: functional sympathetic denervation of adipose tissue and possible hypertrophy of brown fat. Metabolism. 1974 Oct;23(10):937–945. doi: 10.1016/0026-0495(74)90043-2. [DOI] [PubMed] [Google Scholar]
  30. Mosinger B., Kuhn E., Kujalová V. Action of adipokinetic hormones on human adipose tissue in vitro. J Lab Clin Med. 1965 Sep;66(3):380–389. [PubMed] [Google Scholar]
  31. Mounier-Kuhn P., Haguenauer J. P. Localisation laryngee d'une maladie de Launois-Bensaude. J Fr Otorhinolaryngol Audiophonol Chir Maxillofac. 1967 Nov;16(8):603–603. [PubMed] [Google Scholar]
  32. Noble R. P. Electrophoretic separation of plasma lipoproteins in agarose gel. J Lipid Res. 1968 Nov;9(6):693–700. [PubMed] [Google Scholar]
  33. Ostman J., Efendić S. Alpha-adrenergic receptors in human omentum? Lancet. 1969 Jan 25;1(7587):202–202. doi: 10.1016/s0140-6736(69)91214-8. [DOI] [PubMed] [Google Scholar]
  34. SHAMANNA D. Diffuse symmetrical lipomatosis of the face. J Indian Med Assoc. 1955 Jan 1;24(7):263–264. [PubMed] [Google Scholar]
  35. STREHLER B. L., TOTTER J. R. Firefly luminescence in the study of energy transfer mechanisms. I. Substrate and enzyme determination. Arch Biochem Biophys. 1952 Sep;40(1):28–41. doi: 10.1016/0003-9861(52)90070-2. [DOI] [PubMed] [Google Scholar]
  36. Sjöström L., Björntorp P., Vrána J. Microscopic fat cell size measurements on frozen-cut adipose tissue in comparison with automatic determinations of osmium-fixed fat cells. J Lipid Res. 1971 Sep;12(5):521–530. [PubMed] [Google Scholar]
  37. Springer H. A., Whitehouse J. S. Launois-Bensaude adenolipomatosis. Case report. Plast Reconstr Surg. 1972 Sep;50(3):291–294. doi: 10.1097/00006534-197209000-00030. [DOI] [PubMed] [Google Scholar]
  38. Stern M. P., Olefsky J., Farquhar J. W., Reaven G. M. Relationship between fasting plasma lipid levels and adipose tissue morphology. Metabolism. 1973 Oct;22(10):1311–1317. doi: 10.1016/0026-0495(73)90275-8. [DOI] [PubMed] [Google Scholar]
  39. TAYLOR L. M., BEAHRS O. H., FONTANA R. S. Benign symmetric lipomatosis. Proc Staff Meet Mayo Clin. 1961 Feb 15;36:96–100. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES